ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 7, July 2026 | pp. 500–507
DOI: 10.46882/AJIDR/148980
Article Type: Research Article
Title: Molecular epidemiology and miltefosine susceptibility of Leishmania donovani in visceral leishmaniasis relapse cases
Names of Authors: Dawit Tadesse¹*, Lukas Novotny², Fernanda Costa³
Abstract: Visceral leishmaniasis is a life-threatening protozoan infection where post-treatment relapses complicate disease control and contribute to human reservoirs. We evaluated parasite genetic polymorphisms and in vitro miltefosine susceptibility among patients experiencing visceral leishmaniasis relapse. Bone marrow and splenic aspirates from 74 relapsed patients were cultured and assessed via intracellular amastigote susceptibility assays and transporter gene sequencing. Reduced miltefosine susceptibility was detected in 18.9 percent of isolates, associated with point mutations in the LdMT miltefosine transporter gene. Combination therapy with liposomal amphotericin B improves definitive cure rates.
Keywords: Visceral leishmaniasis, Leishmania donovani, Miltefosine resistance, Treatment relapse, Protozoan parasites
Citation: Tadesse D, Novotny L, Costa F (2026). Molecular epidemiology and miltefosine susceptibility of Leishmania donovani in visceral leishmaniasis relapse cases. African Journal of Infectious Diseases Research, 13(7): 500–507. DOI: 10.46882/AJIDR/148980
Manuscript Timeline: Received: May 29, 2026; Revised: June 28, 2026; Accepted: July 15, 2026; Published: July 22, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read